InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 11/28/2019 10:15:22 AM

Thursday, November 28, 2019 10:15:22 AM

Post# of 36
News: $HCM Chi-Med's Elunate® (Fruquintinib Capsules) Included in the National Reimbursement Drug List in China

LONDON, Nov. 28, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM/Nasdaq: HCM) today announces that Elunate ® (fruquintinib capsules), its national class 1 targeted anticancer drug for the treatment of patients with advanced colorectal cancer ...

Got this from HCM - Chi-Med's Elunate® (Fruquintinib Capsules) Included in the National Reimbursement Drug List in China
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HCM News